Position in ARGX
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$208,683,303
+$38,175,042 QoQ
Shares Held
224,930
-3.7% QoQ
Ownership
0.362%
of shares outstanding
% of Portfolio
0.05%
of 13F equity value
Holder Rank
#21
of 504 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 85%
Shared 1%
None 13%
Common Shares in ARGX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026FRANKLIN RESOURCES INC holds $9,179,114,031 across 176 Biotechnology names. ARGX ranks #8 (2.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | REGN |
Regeneron Pharmaceuticals, Inc.
|
2,771,839 | $1,728,352,485 | |
| 2 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
3,347,253 | $1,662,680,977 | |
| 3 | ASND |
Ascendis Pharma A/S
|
1,862,503 | $496,766,798 | |
| 4 | JAZZ |
Jazz Pharmaceuticals plc
|
2,040,250 | $491,639,040 | |
| 5 | RVMD |
Revolution Medicines, Inc.
|
1,488,394 | $278,746,426 | |
| 6 | INSM |
INSMED Inc
|
2,273,222 | $242,370,927 | |
| 7 | LGND |
Ligand Pharmaceuticals Inc
|
752,044 | $237,713,585 | |
| 8 | ARGX |
Argenx SE
This page
|
224,930 | $208,683,303 |
All Filings in ARGX
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $208,683,303 | 224,930 | Shares | Defined | 2026-08-13 | |
| 2026-03-31 | $170,508,261 | 233,493 | Shares | Defined | 2026-05-13 | |
| 2025-12-31 | $199,894,653 | 237,701 | Shares | Defined | 2026-02-11 | |
| 2025-09-30 | $190,492,567 | 258,274 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $154,233,006 | 279,803 | Shares | Defined | 2025-08-12 | |
| 2025-03-31 | $81,202,098 | 137,197 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $82,773,465 | 134,591 | Shares | Defined | 2025-02-12 | |
| 2024-09-30 | $72,648,474 | 134,018 | Shares | Defined | 2024-11-27 | |
| 2024-06-30 | $58,580,906 | 136,222 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $65,787,853 | 167,093 | Shares | Defined | 2024-05-13 | |
| 2023-12-31 | $66,280,795 | 174,226 | Shares | Defined | 2024-02-09 | |
| 2023-09-30 | $89,805,067 | 182,668 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $95,994,785 | 246,311 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $91,907,660 | 246,679 | Shares | Defined | 2023-05-12 | |
| 2022-12-31 | $79,972,905 | 211,105 | Shares | Defined | 2023-02-10 | |
| 2022-09-30 | $74,622,765 | 211,366 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $94,969,302 | 250,658 | Shares | Defined | 2022-08-11 | |
| 2022-03-31 | $79,226,681 | 251,266 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $47,375,103 | 135,284 | Shares | Defined | 2022-02-11 | |
| 2021-09-30 | $40,859,090 | 135,295 | Shares | Defined | 2021-11-12 | |
| 2021-06-30 | $40,583,331 | 134,797 | Shares | Defined | 2021-08-13 | |
| 2021-03-31 | $33,934,381 | 123,223 | Shares | Defined | 2021-05-13 | |
| 2020-12-31 | $60,564,011 | 205,937 | Shares | Defined | 2021-02-10 | |
| 2020-09-30 | $58,362,919 | 222,318 | Shares | Defined | 2020-11-12 | |
| 2020-06-30 | $125,855,370 | 558,786 | Shares | Defined | 2020-08-13 | |
| 2020-03-31 | $75,672,957 | 574,455 | Shares | Defined | 2020-05-13 | |
| No filing history on record for this holder in this stock. | ||||||